About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search

Browse all scholars & fellows by:
- Research Area

SCHOLARS & FELLOWS
AEI Research Appointments
Press Releases

E-NEWSLETTERS
Enter e-mail:
 

Home >  Scholars & Fellows >  Roger Bate >  Speaking Engagements
Speaking Engagements by Roger Bate
Resident Fellow
Resident Fellow Roger Bate
[Hide Abstracts]
AIDS and Africa
Posted: Thursday, March 17, 2005
Time is a necessary component in making safe moral judgements that will lead to a successful and sustainable AIDS relief program in Africa.  [Full Story]
Malaria Policy
Posted: Tuesday, November 30, 2004
If Africa wants to use insecticides, it must ask for support from the Global Fund and the United States because the Global Fund will supply the funds to procure the insecticide.   [Full Story]
Risk, Science, and Public Policy
Posted: Thursday, October 14, 2004
Aid bolsters rent-seekers who apply energy to encouraging government transfers, it damages diversity, and it undervalues and stifles the private sector.  [Full Story]
Malaria in Africa
Posted: Wednesday, September 15, 2004
The United States must fund effective, comprehensive malarial control programs in order to prevent malaria from threatening U.S. interests both at home and abroad.  [Full Story]
Total Records: 24
Previous  ] 
Research Areas
Performance & effectiveness of aid agencies and NGOs in Africa and the developing world
Health policy and endemic diseases in developing countries (HIV/AIDS and malaria)
International environmental and health agreements (industrial chemicals and water)
Water policy in developing countries
Downloads
High-Resolution Photo
Contact Information
Roger Bate
American Enterprise Institute
 1150 Seventeenth Street, N.W.
Washington, DC  20036
Phone: 202-828-6029
Assistant: 202-862-4876
Fax: 202-862-7177
E-mail: RBate@aei.org
Latest Book
Making a Killing
Making a Killing
In this groundbreaking study, Roger Bate traces the burgeoning international trade in counterfeit pharmaceuticals. [Read More]